Haikuo Ma

881 total citations
38 papers, 689 citations indexed

About

Haikuo Ma is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Haikuo Ma has authored 38 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 15 papers in Oncology and 11 papers in Immunology. Recurrent topics in Haikuo Ma's work include Hedgehog Signaling Pathway Studies (10 papers), interferon and immune responses (7 papers) and Cell death mechanisms and regulation (6 papers). Haikuo Ma is often cited by papers focused on Hedgehog Signaling Pathway Studies (10 papers), interferon and immune responses (7 papers) and Cell death mechanisms and regulation (6 papers). Haikuo Ma collaborates with scholars based in China, United States and Poland. Haikuo Ma's co-authors include Xiaohu Zhang, Zhiguo Zhu, Hongying Lü, Jiyue Zheng, Sudan He, Sheng Tian, Lusong Luo, Ting Su, Weiping Liao and Hongjian Zhang and has published in prestigious journals such as Journal of Hazardous Materials, Applied Catalysis B: Environmental and Chemical Communications.

In The Last Decade

Haikuo Ma

37 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haikuo Ma China 18 343 160 137 136 130 38 689
Rajesh Manne India 16 349 1.0× 242 1.5× 116 0.8× 140 1.0× 71 0.5× 29 755
Chongyang Wei China 12 313 0.9× 119 0.7× 244 1.8× 23 0.2× 58 0.4× 24 805
Moira A. Elliott United Kingdom 13 285 0.8× 66 0.4× 65 0.5× 77 0.6× 50 0.4× 40 737
Claudia Piutti Italy 9 337 1.0× 99 0.6× 36 0.3× 476 3.5× 17 0.1× 12 867
Qingqing Zhang China 18 493 1.4× 112 0.7× 122 0.9× 537 3.9× 8 0.1× 59 1.3k
Jiahua Zhou China 13 294 0.9× 39 0.2× 53 0.4× 35 0.3× 22 0.2× 37 483
Wenjun Yu China 13 270 0.8× 32 0.2× 70 0.5× 59 0.4× 11 0.1× 29 458
Joji Nishikido Japan 20 350 1.0× 14 0.1× 119 0.9× 552 4.1× 25 0.2× 30 927
Zeyu Wu China 15 209 0.6× 47 0.3× 28 0.2× 38 0.3× 12 0.1× 45 595

Countries citing papers authored by Haikuo Ma

Since Specialization
Citations

This map shows the geographic impact of Haikuo Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haikuo Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haikuo Ma more than expected).

Fields of papers citing papers by Haikuo Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haikuo Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haikuo Ma. The network helps show where Haikuo Ma may publish in the future.

Co-authorship network of co-authors of Haikuo Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Haikuo Ma. A scholar is included among the top collaborators of Haikuo Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haikuo Ma. Haikuo Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ji, Yuting, Jingjing Li, Haikuo Ma, et al.. (2025). Discovery of Zharp1-163 as a dual inhibitor of ferroptosis and necroptosis for the treatment of inflammatory disorders and kidney injury. Cell Death Discovery. 11(1). 413–413.
2.
Yu, Xiaoliang, Zhanhui Li, S. C. Wu, et al.. (2023). Synthesis and evaluation of dihydrofuro[2,3-b]pyridine derivatives as potent IRAK4 inhibitors. European Journal of Medicinal Chemistry. 258. 115616–115616. 5 indexed citations
3.
Wang, Jin, Xiaoliang Yu, Zhanhui Li, et al.. (2023). Design, synthesis, evaluation and optimization of potent IRAK4 inhibitors alleviating production of inflammatory cytokines in LPS-induced SIRS model. Bioorganic Chemistry. 137. 106584–106584. 7 indexed citations
4.
Yang, Chengkui, Chang Shu, Zhanhui Li, et al.. (2022). Discovery, optimization and evaluation of isothiazolo[5,4-b]pyridine derivatives as RIPK1 inhibitors with potent in vivo anti-SIRS activity. Bioorganic Chemistry. 129. 106051–106051. 2 indexed citations
5.
Li, Zhanhui, Chengkui Yang, Qing Yang, et al.. (2021). Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity. European Journal of Medicinal Chemistry. 228. 114036–114036. 15 indexed citations
6.
Wu, S. C., Xu Chen, Lin Yu, et al.. (2021). Ring closure strategy leads to potent RIPK3 inhibitors. European Journal of Medicinal Chemistry. 217. 113327–113327. 19 indexed citations
7.
Zhu, Fang, Chengkui Yang, S. C. Wu, et al.. (2020). Discovery of a Potent RIPK3 Inhibitor for the Amelioration of Necroptosis-Associated Inflammatory Injury. Frontiers in Cell and Developmental Biology. 8. 606119–606119. 38 indexed citations
8.
Ju, Jie, Zili Zhang, Cong Zhao, et al.. (2019). Discovery of potent necroptosis inhibitors targeting RIPK1 kinase activity for the treatment of inflammatory disorder and cancer metastasis. Cell Death and Disease. 10(7). 77 indexed citations
9.
Zhu, Fang, Yujie Wang, Qian Du, et al.. (2019). Structural optimization of aminopyrimidine-based CXCR4 antagonists. European Journal of Medicinal Chemistry. 187. 111914–111914. 11 indexed citations
10.
Song, Shiwei, Jin-Yi Jiang, Li Zhao, et al.. (2019). Structural optimization on a virtual screening hit of smoothened receptor. European Journal of Medicinal Chemistry. 172. 1–15. 7 indexed citations
11.
Chen, Qin, Haoran Zhang, Meng Wu, et al.. (2018). Discovery of a potent hedgehog pathway inhibitor capable of activating caspase8-dependent apoptosis. Journal of Pharmacological Sciences. 137(3). 256–264. 14 indexed citations
12.
Ma, Haikuo, Qin Chen, Fang Zhu, et al.. (2018). Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor. European Journal of Medicinal Chemistry. 149. 110–121. 9 indexed citations
13.
Lu, Wenfeng, Dihua Zhang, Haikuo Ma, et al.. (2018). Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays. European Journal of Medicinal Chemistry. 155. 34–48. 24 indexed citations
14.
Li, Zhanhui, Yujie Wang, Chunyan Fu, et al.. (2018). Design, synthesis, and structure-activity-relationship of a novel series of CXCR4 antagonists. European Journal of Medicinal Chemistry. 149. 30–44. 16 indexed citations
15.
Xu, Xiangxiang, Haikuo Ma, Jiyue Zheng, et al.. (2016). Design, synthesis, and evaluation of novel porcupine inhibitors featuring a fused 3-ring system based on the ‘reversed’ amide scaffold. Bioorganic & Medicinal Chemistry. 24(22). 5861–5872. 17 indexed citations
16.
Yang, Zhaohui, Haikuo Ma, Zhijian Sun, et al.. (2015). Discovery of a 6-(pyridin-3-yl)benzo[d]thiazole template for optimization of hedgehog and PI3K/AKT/mTOR dual inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(17). 3665–3670. 17 indexed citations
17.
Wu, Jing, Jiyue Zheng, Haikuo Ma, et al.. (2015). Design, synthesis and evaluation of a series of non-steroidal anti-inflammatory drug conjugates as novel neuroinflammatory inhibitors. International Immunopharmacology. 25(2). 528–537. 22 indexed citations
18.
Dong, Yan, Kehuang Li, Haikuo Ma, et al.. (2015). Exploration of the linkage elements of porcupine antagonists led to potent Wnt signaling pathway inhibitors. Bioorganic & Medicinal Chemistry. 23(21). 6855–6868. 17 indexed citations
19.
Lu, Wenfeng, Zhijian Sun, Zhaohui Yang, et al.. (2014). Scaffold hopping approach to a new series of smoothened antagonists. Bioorganic & Medicinal Chemistry Letters. 24(10). 2300–2304. 20 indexed citations
20.
Ma, Haikuo, Huan‐Qiu Li, & Xiaohu Zhang. (2013). Cyclopamine, a Naturally Occurring Alkaloid, and Its Analogues May Find Wide Applications in Cancer Therapy. Current Topics in Medicinal Chemistry. 13(17). 2208–2215. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026